Trial intelligence / Profile preview

Dexmedetomidine Bolus ED50/ED95 for Hemodynamic Stability

NCT03655847Phase 4Unknown

Sponsor
The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
Start
May 2018
Primary completion
Mar 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of dexmedetomidine in hemodynamic instability, postoperative complications, sponsored by The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University. Status: unknown.

02

Drugs

dexmedetomidine
03

Conditions

hemodynamic instabilitypostoperative complications

Beyond the preview

Go deeper on NCT03655847.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03655847.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call